HER2 Support Group Forums - View Single Post - FDA approves new treatment to reduce the risk of breast cancer returning

News · 07-18-2017, 07:24 AM

The U.S. Food and Drug Administration has approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer.

More...

07-18-2017, 07:24 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,950	FDA approves new treatment to reduce the risk of breast cancer returning The U.S. Food and Drug Administration has approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. More...